Pharma Marketing Network Home

John Mack

Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.



We accept advertising relevant to the interests of our members.
For more information, see:

Media Kit





Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
Pharma Marketing Blog


My Humble Opinion
Pharma Marketing Blog
Other People's Opinion
Pharma Marketing Talk
A "Must Read" Blog for Insiders. -- Wall Street Journal A bi-weekly podcast. Listen and call-in live online or download to your iPod!

| Also see Pharma Marketing News OpEd Pieces |

DTC Here to Stay; Pet Turtles Too!

Posted: September 21, 2007

The Food and Drug Administration Revitalization Act (S.1082) has been approved by Congress (see "Congress Expands FDA's Oversight On Drug Safety") and will soon be signed into law (you can read the entire bill here).

Two provisions -- or lack thereof -- of this law stood out to me: (1) a one- or two-year moratorium on direct-to-consumer (DTC) ads for all new drugs did not make it into the bill, and (2) a provision prohibiting the FDA from restricting the sale of turtles less than 10.2 centimeters in diameter as a pet DID make it into the bill (Title VII - Domestic Pet Turtle Market Access; Section 703).

What's the connection between DTC and pet turtles? What new powers over DTC does S.1082 give to the FDA? Did the drug industry get a "Get Out of Jail Free" card on DTC fines?

Read more about this in today's post to Pharma Marketing Blog.

For more posts in related topic areas, see:

If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.

Enter your Email Address

| Return to Pharma Marketing Blog Topics |

Special Supplement
Direct-to-Consumer Advertising
Volume Two: DTC in the New Era

DTC Vol 2 Supplement Cover
DTC advertising is set for major changes in light of public criticism, but also in reaction to the changing reality of the marketplace where there is less need for a one size fits all solution. DTC must evolve and marketers must pay more attention to measuring and improving its effectiveness. Otherwise, billions of dollars will continue to be wasted. This volume is devoted to DTC best practices with a focus on techniques for improving DTC efficacy and return on investment, which is generally considered to be declining.

TABLE OF CONTENTS

Order both Volume One and Volume Two and SAVE! (Click Here)

Order and pay for Volume Two now using your credit card.

ONLY $29.95
PDF file delivered to you by email (usually within minutes of placing your order):

If you wish to be pay by check or credit card off-line, please use:
Printable Order Form


Pharma Marketing News | Subscribe | Discussion Forums | Roundtable | Podcasts | Blog
Daily News Briefs | Surveys | Resources/Links | Glossary | Case Studies | Reports
Pharma Marketing Vendor Directory | Conference Calendar | Pharma Jobs
Advertising Information | FAQs | About Us | Privacy Policy

© 2007. VirSci Corporation. All rights reserved.